| PUBCHEM ID |
112500547
|
| UNII |
FT8JPL34R7
|
| Preferred Term |
BISPREHOMOTADALAFIL
|
| CAS |
1803592-02-0
|
| INCHIKEY |
HXPQHEXUZQQJMO-RKTRKJHVSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCN(CC(N([C@@H](Cc1c2[nH]c3c1cccc3)C(OC)=O)[C@@H]2c(cc1)cc2c1OCO2)=O)CC(N([C@@H](Cc1c2[nH]c3c1cccc3)C(OC)=O)[C@@H]2c(cc1)cc2c1OCO2)=O
|
| Total Surface Area |
591,88
|
| Relative PSA |
0,25476
|
| TPSA |
164,96
|
| cLogS |
-7,263
|
| MW |
825,872
|
| cLogP |
5,6175
|
| H-Acceptors |
15
|
| H-Donors |
2
|
| Ro5 violations |
3
|
| Druglikeness |
3,8146
|
| DrugScore |
0,14903664550187
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
low
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,8207
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,2616
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,3727
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,7181
|
| Carcinogenicity (Three-class) |
Non-required
|
